Not Yet RecruitingNot Applicable

Electromyographic Biofeedback Therapy in Patients With Dyssynergic Defecation

Turkey (Türkiye)36 participantsStarted 2026-03-31

Plain-language summary

This study aimed to investigate the effects of game-based electromyographic (EMG) biofeedback therapy on the quality of life and sleep quality of individuals diagnosed with dyssynergic defecation.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Diagnosis of dyssynergic defecation was confirmed by anorectal manometry, which demonstrated paradoxical pelvic floor muscle contraction and/or inadequate relaxation during defecation.
✓. Eligibility for a pelvic floor rehabilitation program was based on a comprehensive evaluation conducted at the Physical Medicine and Rehabilitation Clinic.
✓. Age between 18 and 70 years.
✓. A history of chronic constipation lasting at least six months, in accordance with the Rome IV diagnostic criteria.
✓. Stool consistency was classified as type 1 or type 2 according to the Bristol Stool Scale, indicating a hard stool pattern.

Exclusion criteria

✕. Presence of communication barriers that may interfere with participation in the study.
✕. Cognitive impairment affects the ability to comply with rehabilitation programs or assessments.
✕. Pregnancy.
✕. Presence of severe depression and/or anxiety disorder.
✕. Untreated metabolic or endocrine disorders, including but not limited to diabetes mellitus, hypothyroidism, hypokalemia, and hypercalcemia.
✕. Use of medications known to cause or exacerbate constipation.
✕. History of spinal, rectal, or pelvic surgery, excluding cholecystectomy, hysterectomy, and appendectomy.
✕. Presence of colorectal malignancy or inflammatory bowel disease.

What they're measuring

Patient Assessment of Constipation-Quality of Life Questionnaire

Timeframe: At baseline, immediately after the intervention, and 2-months after the intervention.

Trial details

NCT IDNCT07482696

SponsorKocaeli University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10-31

Contact for this trial

Tugba Gokbel, Assistant Prof, MD

+905442877390 tugbagokbelftr@gmail.com

View on ClinicalTrials.gov More Defecation Disorder trials